SCHEMBL3840461

SCHEMBL3840461

c1ccc2c(OB(Oc3cccc4ccccc34)Oc3cccc4ccccc34)cccc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
HSD17B10 Q99714 4/20 0.48
PGR P06401 1/20 0.48
GAA P10253 1/20 0.48
PTGS1 P23219 1/20 0.48
MAPK1 P28482 1/20 0.48
HTR1B P28222 7/20 0.48
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
RAB9A P51151 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KDM4E B2RXH2 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
KCNA3 P22001 1/20 0.46
HPGD P15428 1/20 0.46
HTR1D P28221 1/20 0.44
CYP2A6 P11509 1/20 0.43
TSHR P16473 1/20 0.43
SLC6A4 P31645 1/20 0.43
HRH1 P35367 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21809379 0.87 HPRT1 (0.56) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL6851541 0.83 ALDH1A1 (0.46) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL28864172 0.82 ALDH1A1 (0.40) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL29405949 0.82 ALDH1A1 (0.50) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL17333246 0.82 ALDH1A1 (0.50) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL17333244 0.82 KMT2A (0.53) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL1208635 0.82 ALDH1A1 (0.50) ALDH1A1HSD17B10PGRGAAPTGS1
Butylamine SCHEMBL1146873 0.81 HTR1B (0.57) HTR1BHTR1DSLC6A4HRH1NR2E1
SCHEMBL4918884 0.80 ALDH1A1 (0.49) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL28694633 0.80 ALDH1A1 (0.49) ALDH1A1HSD17B10PGRGAAPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111592558-B Heterocyclic compound having uric acid reabsorption inhibiting effect 北京桦冠医药科技有限公司 2021-09-07 CN claimed
CN-111592558-A Heterocyclic compound having uric acid reabsorption inhibiting effect 北京桦冠医药科技有限公司 2020-08-28 CN claimed
EP-0561630-B1 Polycarbonate resin compositions for optical use GE PLASTICS JAPAN LTD (JP) 1999-12-29 EP claimed
US-5403878-A With alpha olefin oligomer and acidic sulfur compound; mold releasing, thermostability CITIBANK, N.A., AS COLLATERAL AGENT 1995-04-04 US claimed
US-5389713-A Polycarbonate formed by melt polymerization of aromatic dihydroxy compound and carbonate diester, alpha-olefin oligomer, acidic sulfur-containing compound GE PLASTICS JAPAN (JP) 1995-02-14 US claimed
US-5286834-A Condensing bisphenol A and biphenol with a carbonate diester GE PLASTICS JAPAN, LTD. (JP) 1994-02-15 US claimed
US-12043636-B2 Method for producing triarylorganoborates COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2024-07-23 US disclosed
CN-118076660-A Photocurable composition, cured product, laminate, method for producing cured product, and method for producing lens 三井化学株式会社 2024-05-24 CN disclosed
US-20240002409-A1 METHOD FOR PRODUCING TRIARYLORGANOBORATES COVESTRO DEUTSCHLAND AG (DE) 2024-01-04 US disclosed
CN-116891602-A Ultra-high molecular weight polyethylene powder and molded article 旭化成株式会社 2023-10-17 CN disclosed
CN-116829989-A Photocurable composition, cured product thereof, and optical material containing the cured product 三菱瓦斯化学株式会社 2023-09-29 CN disclosed
US-11760765-B2 Method for producing triarylorganoborates COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2023-09-19 US disclosed
WO-2023156482-A1 THERMOSTABLE PHOTOPOLYMERS IN THE VISIBLE SPECTRAL RANGE AND PHOTOPOLYMER COMPOSITIONS CONTAINING SAME COVESTRO DEUTSCHLAND AG (DE) 2023-08-24 WO disclosed
EP-0520806-A2 Optical polycarbonate compositions GE PLASTICS JAPAN LIMITED (JP) 1992-12-30 EP disclosed
EP-0520805-A2 Polycarbonate production method GE PLASTICS JAPAN LIMITED (JP) 1992-12-30 EP disclosed
EP-0508775-A2 Method of producing copolymerized polycarbonates GE PLASTICS JAPAN LIMITED (JP) 1992-10-14 EP disclosed
EP-0508774-A2 Copolymerized polycarbonates GE PLASTICS JAPAN LIMITED (JP) 1992-10-14 EP disclosed
US-5151491-A Nitrogen compound, a boric acid compound and a dihydroxy compound terminated with a monoalcohol GE PLASTICS JAPAN, LTD. (JP) 1992-09-29 US disclosed
EP-0434998-A2 Polycarbonate or polyestercarbonate resin compositions and preparing methods thereof GE PLASTICS JAPAN LIMITED (JP) 1991-07-03 EP disclosed
EP-0360578-A2 Process for the production of polycarbonates GE PLASTICS JAPAN LTD. (JP) 1990-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240002409-A1 METHOD FOR PRODUCING TRIARYLORGANOBORATES KMO, COASY, CYP3A4 ALDH1A1 2226/4885HSD17B10 112/4885PGR 3263/4885
US-12043636-B2 Method for producing triarylorganoborates KMO, COASY, CYP3A4 ALDH1A1 2226/4885HSD17B10 112/4885PGR 3263/4885
US-11760765-B2 Method for producing triarylorganoborates CYP3A4, CYP3A43, CYP4B1 ALDH1A1 1623/4885HSD17B10 71/4885PGR 3572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.